Trulieve Cannabis Corp. (CSE: TRUL)

Market Cap	1.68B
Revenue (ttm)	1.58B
Net Income (ttm)	-173.94M
Shares Out	189.68M
EPS (ttm)	-0.92
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	201,335
Open	8.70
Previous Close	8.55
Day's Range	8.65 - 8.90
52-Week Range	6.31 - 20.00
Beta	1.43
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About Trulieve Cannabis

Trulieve Cannabis Corp., together with its subsidiaries, operates as a cannabis retailer. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, creams, balms, salves, lotions, vaporizers, batteries, cartridge, concentrates, topicals, capsules, synringes, tinctures, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, Trekkers, and Roll One bran...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1940
• Employees: 5,400
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: TRUL

Financial Performance

In 2023, Trulieve Cannabis's revenue was $1.13 billion, a decrease of -7.31% compared to the previous year's $1.22 billion. Losses were -$526.80 million, 114.1% more than in 2022.

Financial numbers in USD